▲ SIGMATERMINAL Open Terminal →

Analyses / PLTR

PLTR Palantir Technologies Inc As of Sep 15, 2026
$173.31

High-growth AI/data platform: strong revenue momentum but elevated valuation multiples and insider selling pressure warrant caution.

Setup: growth_momentum_with_valuation_risk Confidence: 62 Horizon: 3-6 months Risk: high Category: Large-cap Growth / Technology
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals PLTR's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

32.9% revenue growth, 36.3% net margins, fortress balance sheet (7.1x current ratio), AI tailwinds driving demand. Trading 16% below 52-week high; potential inflection if guidance exceeds consensus and margin expansion accelerates.

▼ Bear Case

P/E 133x, P/S 90x, EV/EBITDA 297x are extreme even for growth. Forward P/E 247x signals priced-for-perfection. Insider sellers outnumber buyers 8.8:1 (343 sells vs 39 buys). Analyst downgrades noted; data risk concerns emerging.

Valuation

OVERVALUED — score 22/100

Multiples are extreme across the board. P/E 133x, P/S 90x, EV/EBITDA 297x, and forward P/E 247x far exceed growth rates (32.9% revenue growth). Even high-growth SaaS peers trade 8–15x revenue; PLTR at 90x is an outlier. Fair-value scenarios suggest 30–50% downside if growth disappoints or multiple mean-reverts.

Technical Levels

Support · $165.00 (Recent intraday low (1-day support)) · $155.00 (~10% below current; potential 2nd support) · $140.00 (Psychological 10% pullback zone)

Resistance · $180.00 (~3.9% above current; near-term target) · $195.00 (~12% above current; prior resistance zone) · $207.52 (52-week high; major resistance)

RSI: Not provided in payload

Financial Health

Score 78/100. Balance sheet appears fortress-like: 7.1x current ratio indicates ample cash and short-term liquidity. Margins are exceptional—82% gross, 36% net—suggesting strong pricing and operational efficiency. Debt ratios unavailable; recommend checking 10-Q to confirm leverage is conservative. Overall, financial health is solid, but valuation multiples are not supported by balance sheet fortress alone.

Catalysts

Next earnings report (Q4 2024 or Q1 2025 expected)~4-8 weekshigh
2025 guidance raise (if revenue growth re-accelerates to 40%+)Earnings or investor dayhigh
Major enterprise AI deal announcements (e.g., Fortune 500 adoption)Ongoing, unpredictablemedium
Insider selling continuation or unusual buying (sentiment shift)Ongoing SEC filingsmedium
AI regulatory risk or data privacy concerns (e.g., Anthropic/OpenAI restrictions)Policy-dependentmedium

Risk Flags

Valuation multiples (P/E 133x, P/S 90x, EV/EBITDA 297x) are extreme; any miss or growth deceleration could trigger sharp repricing.
Insider selling heavily outweighs buying (343 sells, 39 buys). Net shares sold 6.2M; may signal insiders view current price unsustainable.
Forward P/E 247x and absence of PEG ratio suggest growth expectations embedded in price; margin of safety is thin.
Recent news hints at AI data-risk concerns (Anthropic/OpenAI model restrictions); regulatory or reputational headwinds could pressure margin.
Provider data lacks earnings history, cash flow details, debt ratios. Recommend review of latest 10-Q/10-K and earnings call transcripts.

See PLTR's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock PLTR free →

Recent News

More Analyses

PLTR FAQ

Is PLTR a buy right now?

Palantir Technologies Inc's current read is a growth_momentum_with_valuation_risk setup with 62 confidence over a 3-6 months horizon. Valuation: OVERVALUED. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is PLTR overvalued?

OVERVALUED (valuation score 22/100). Multiples are extreme across the board. P/E 133x, P/S 90x, EV/EBITDA 297x, and forward P/E 247x far exceed growth rates (32.9% revenue growth). Even high-growth SaaS peers trade 8–15x revenue; PLTR at 90x is an outlier. Fair-value scenarios suggest 30–50% downside if growth disappoints or multiple mean-reverts.

What are the risks of buying PLTR?

P/E 133x, P/S 90x, EV/EBITDA 297x are extreme even for growth. Forward P/E 247x signals priced-for-perfection. Insider sellers outnumber buyers 8.8:1 (343 sells vs 39 buys). Analyst downgrades noted; data risk concerns emerging.